TRUP has been the topic of several other reports. BidaskClub upgraded shares of Trupanion from a hold rating to a buy rating in a report on Saturday, February 9th. Zacks Investment Research downgraded shares of Trupanion from a buy rating to a hold rating in a research report on Tuesday, February 19th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of $44.38.
Shares of Trupanion stock traded down $0.79 on Thursday, hitting $34.70. The company’s stock had a trading volume of 237,493 shares, compared to its average volume of 288,357. The firm has a market capitalization of $1.21 billion, a PE ratio of -1,156.67 and a beta of 1.19. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.10. Trupanion has a 52-week low of $22.38 and a 52-week high of $46.70.
Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 13th. The financial services provider reported ($0.01) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.01 by ($0.02). The firm had revenue of $82.64 million during the quarter, compared to analysts’ expectations of $82.16 million. Trupanion had a negative net margin of 0.30% and a negative return on equity of 0.88%. The business’s revenue for the quarter was up 24.2% on a year-over-year basis. On average, research analysts expect that Trupanion will post 0.11 EPS for the current fiscal year.
In other Trupanion news, CRO Margaret Tooth sold 1,000 shares of the stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $29.73, for a total value of $29,730.00. Following the completion of the sale, the executive now owns 4,693 shares of the company’s stock, valued at $139,522.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $27.14, for a total transaction of $108,560.00. Following the completion of the sale, the insider now directly owns 1,555,421 shares of the company’s stock, valued at approximately $42,214,125.94. The disclosure for this sale can be found here. Insiders sold 165,786 shares of company stock valued at $4,970,963 in the last ninety days. 20.70% of the stock is owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the stock. RV Capital GmbH bought a new stake in Trupanion in the fourth quarter valued at $15,039,000. Wells Fargo & Company MN increased its holdings in shares of Trupanion by 927.2% during the third quarter. Wells Fargo & Company MN now owns 478,209 shares of the financial services provider’s stock valued at $17,087,000 after purchasing an additional 431,653 shares during the period. Handelsbanken Fonder AB increased its holdings in shares of Trupanion by 65.0% during the fourth quarter. Handelsbanken Fonder AB now owns 660,000 shares of the financial services provider’s stock valued at $16,804,000 after purchasing an additional 260,000 shares during the period. Millennium Management LLC increased its holdings in shares of Trupanion by 1,006.9% during the fourth quarter. Millennium Management LLC now owns 284,032 shares of the financial services provider’s stock valued at $7,231,000 after purchasing an additional 258,372 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in shares of Trupanion by 19.3% during the third quarter. Alliancebernstein L.P. now owns 1,556,323 shares of the financial services provider’s stock valued at $55,607,000 after purchasing an additional 251,931 shares during the period. Hedge funds and other institutional investors own 97.10% of the company’s stock.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Article: Using other technical indicators with support levels
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.